Skip to main content
logo
Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.9230
+0.0130 (1.43%)
At close: Apr 10, 2026

BCLI Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.030.191.30.7718.86
Short-Term Investments
---2.213.24
Cash & Short-Term Investments
0.030.191.32.9822.09
Cash Growth
-84.49%-85.61%-56.42%-86.50%-47.32%
Other Receivables
0.090.060.050.090.09
Receivables
0.090.060.050.090.09
Prepaid Expenses
0.190.140.550.031.1
Total Current Assets
0.310.391.93.1123.28
Property, Plant & Equipment
0.441.242.15.315.95
Other Intangible Assets
--00.010.02
Other Long-Term Assets
0.270.210.210.020.03
Total Assets
1.021.834.218.4529.28
Accounts Payable
7.076.084.956.223.7
Accrued Expenses
0.40.621.240.080.08
Short-Term Debt
0.970.3---
Current Portion of Leases
0.210.550.61.431.46
Other Current Liabilities
2.371.4311.071.07
Total Current Liabilities
11.018.987.88.86.32
Long-Term Leases
-0.170.672.673.62
Other Long-Term Liabilities
-0.450.59--
Total Liabilities
11.019.69.0711.479.94
Common Stock
0.020.010.010.010.01
Additional Paid-In Capital
227.06218.97210.26194.91192.99
Retained Earnings
-236.94-226.64-215.01-197.82-173.54
Treasury Stock
-0.12-0.12-0.12-0.12-0.12
Shareholders' Equity
-9.99-7.76-4.86-3.0219.34
Total Liabilities & Equity
1.021.834.218.4529.28
Total Debt
1.181.021.284.095.08
Net Cash (Debt)
-1.15-0.830.03-1.1117.02
Net Cash Growth
-----50.99%
Net Cash Per Share
-0.12-0.170.01-0.467.05
Filing Date Shares Outstanding
11.036.524.562.452.43
Total Common Shares Outstanding
11.036.144.032.452.43
Working Capital
-10.7-8.59-5.9-5.6916.96
Book Value Per Share
-0.90-1.26-1.20-1.237.97
Tangible Book Value
-9.99-7.76-4.86-3.0219.33
Tangible Book Value Per Share
-0.90-1.26-1.21-1.247.96
Machinery
2.352.352.362.352.35
Leasehold Improvements
0.840.840.840.840.81
Source: S&P Global Market Intelligence. Standard template. Financial Sources.